{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T14:42:21Z","timestamp":1793544141563,"version":"4.5.0"},"reference-count":43,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006108","name":"National Center for Advancing Translational Sciences","doi-asserted-by":"publisher","award":["TL1TR002555"],"award-info":[{"award-number":["TL1TR002555"]}],"id":[{"id":"10.13039\/100006108","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009633","name":"Eunice Kennedy Shriver National Institute of Child Health and Human Development","doi-asserted-by":"publisher","award":["1K23HD104517"],"award-info":[{"award-number":["1K23HD104517"]}],"id":[{"id":"10.13039\/100009633","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["ajogmfm.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Obstetrics & Gynecology MFM"],"published-print":{"date-parts":[[2023,2]]},"DOI":"10.1016\/j.ajogmf.2022.100731","type":"journal-article","created":{"date-parts":[[2022,8,24]],"date-time":"2022-08-24T01:52:40Z","timestamp":1661305960000},"page":"100731","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":33,"special_numbering":"S","title":["Preventing postpartum hemorrhage with combined therapy rather than oxytocin alone"],"prefix":"10.1016","volume":"5","author":[{"given":"Amanda J.","family":"Jones","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jerome J.","family":"Federspiel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0070-9840","authenticated-orcid":false,"given":"Ahizechukwu C.","family":"Eke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ajogmf.2022.100731_bib0001","doi-asserted-by":"crossref","first-page":"e168","DOI":"10.1097\/AOG.0000000000002351","article-title":"Practice Bulletin No. 183: postpartum hemorrhage","volume":"130","year":"2017","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajogmf.2022.100731_bib0002","doi-asserted-by":"crossref","first-page":"e323","DOI":"10.1016\/S2214-109X(14)70227-X","article-title":"Global causes of maternal death: a WHO systematic analysis","volume":"2","author":"Say","year":"2014","journal-title":"Lancet Glob Health"},{"key":"10.1016\/j.ajogmf.2022.100731_bib0003","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajog.2010.01.011","article-title":"Trends in postpartum hemorrhage: United States, 1994-2006","volume":"202","author":"Callaghan","year":"2010","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajogmf.2022.100731_bib0004","series-title":"WHO recommendations uterotonics for the prevention of postpartum haemorrhage","year":"2018"},{"key":"10.1016\/j.ajogmf.2022.100731_bib0005","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.ajog.2014.07.012","article-title":"Comprehensive maternal hemorrhage protocols reduce the use of blood products and improve patient safety","volume":"212","author":"Shields","year":"2015","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajogmf.2022.100731_bib0006","article-title":"Active versus expectant management for women in the third stage of labour","volume":"2","author":"Begley","year":"2019","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.ajogmf.2022.100731_bib0007","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1056\/NEJMra1513247","article-title":"Postpartum hemorrhage","volume":"384","author":"Bienstock","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ajogmf.2022.100731_bib0008","first-page":"79","article-title":"Oxytocin infusion after oxytocin bolus and carbetocin bolus to reduce blood loss during and after cesarean section-a randomized clinical trial","volume":"83","author":"Fahmy","year":"2015","journal-title":"Med J Cairo Univ"},{"key":"10.1016\/j.ajogmf.2022.100731_bib0009","article-title":"Uterotonic agents for preventing postpartum haemorrhage: a network meta-analysis","volume":"12","author":"Gallos","year":"2018","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.ajogmf.2022.100731_bib0010","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.ajog.2021.08.060","article-title":"Preventing postpartum hemorrhage after cesarean delivery: a network meta-analysis of available pharmacologic agents","volume":"226","author":"Jaffer","year":"2022","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajogmf.2022.100731_bib0011","article-title":"Uterotonic agents for first-line treatment of postpartum haemorrhage: a network meta-analysis","volume":"11","author":"Parry Smith","year":"2020","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.ajogmf.2022.100731_bib0012","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD001808.pub2","article-title":"Prophylactic oxytocin for the third stage of labour to prevent postpartum haemorrhage","author":"Westhoff","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.ajogmf.2022.100731_bib0013","series-title":"WHO recommendations for the prevention and treatment of postpartum haemorrhage","year":"2012"},{"key":"10.1016\/j.ajogmf.2022.100731_bib0014","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1111\/1471-0528.16645","article-title":"Oxytocin: still the optimal prophylactic despite soaring rates of haemorrhage at birth","volume":"128","author":"Weeks","year":"2021","journal-title":"BJOG"},{"key":"10.1016\/j.ajogmf.2022.100731_bib0015","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1111\/j.2042-7158.1995.tb06716.x","article-title":"Bioavailability and pharmacokinetics of sublingual oxytocin in male volunteers","volume":"47","author":"De Groot","year":"1995","journal-title":"J Pharm Pharmacol"},{"key":"10.1016\/j.ajogmf.2022.100731_bib0016","article-title":"Intravenous versus intramuscular prophylactic oxytocin for the third stage of labour","volume":"11","author":"Oladapo","year":"2020","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.ajogmf.2022.100731_bib0017","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.tjog.2013.01.010","article-title":"Effect of intraumbilical vein oxytocin injection on third stage of labor","volume":"52","author":"Nankali","year":"2013","journal-title":"Taiwan J Obstet Gynecol"},{"key":"10.1016\/j.ajogmf.2022.100731_bib0018","article-title":"Prophylactic oxytocin for the third stage of labour to prevent postpartum haemorrhage","volume":"4","author":"Salati","year":"2019","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.ajogmf.2022.100731_bib0020","first-page":"528","article-title":"Pharmacokinetics of carbetocin, a long acting oxytocin analogue, in nonpregnant women","volume":"47","author":"Sweeney","year":"1990","journal-title":"Curr Ther Res"},{"key":"10.1016\/j.ajogmf.2022.100731_bib0021","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1056\/NEJMoa1805489","article-title":"Heat-stable carbetocin versus oxytocin to prevent hemorrhage after vaginal birth","volume":"379","author":"Widmer","year":"2018","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ajogmf.2022.100731_bib0022","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1007\/s12630-020-01779-1","article-title":"Carbetocin compared with oxytocin in non-elective cesarean delivery: a systematic review, meta-analysis, and trial sequential analysis of randomized-controlled trials","volume":"67","author":"Onwochei","year":"2020","journal-title":"Can J Anaesth"},{"key":"10.1016\/j.ajogmf.2022.100731_bib0023","doi-asserted-by":"crossref","first-page":"2303","DOI":"10.1080\/14767058.2019.1664463","article-title":"Efficacy of carbetocin in the prevention of postpartum hemorrhage: a systematic review and Bayesian meta-analysis of randomized trials","volume":"34","author":"Kalafat","year":"2021","journal-title":"J Matern Fetal Neonatal Med"},{"key":"10.1016\/j.ajogmf.2022.100731_bib0024","first-page":"517","article-title":"[Pharmacological basis for the therapeutic use of ergot alkaloids]","volume":"12","author":"Tran","year":"1983","journal-title":"Presse Med"},{"key":"10.1016\/j.ajogmf.2022.100731_bib0025","first-page":"386","article-title":"Clinical pharmacokinetics of methylergometrine (methylergonovine)","volume":"19","author":"M\u00e4ntyl\u00e4","year":"1981","journal-title":"Int J Clin Pharmacol Ther Toxicol"},{"key":"10.1016\/j.ajogmf.2022.100731_bib0026","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/S1521-6934(03)00043-9","article-title":"Pharmacokinetics of prostaglandins","volume":"17","author":"Bygdeman","year":"2003","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"key":"10.1016\/j.ajogmf.2022.100731_bib0027","doi-asserted-by":"crossref","first-page":"S160","DOI":"10.1016\/j.ijgo.2007.09.004","article-title":"Misoprostol: pharmacokinetic profiles, effects on the uterus and side-effects","volume":"99","author":"Tang","year":"2007","journal-title":"Int J Gynaecol Obstet"},{"key":"10.1016\/j.ajogmf.2022.100731_bib0028","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1002\/ijgo.14116","article-title":"FIGO recommendations on the management of postpartum hemorrhage 2022","volume":"157","author":"Escobar","year":"2022","journal-title":"Int J Gynaecol Obstet"},{"key":"10.1016\/j.ajogmf.2022.100731_bib0029","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1159\/000516631","article-title":"Prostaglandins for postpartum hemorrhage: pharmacology, application, and current opinion","volume":"106","author":"Chen","year":"2021","journal-title":"Pharmacology"},{"key":"10.1016\/j.ajogmf.2022.100731_bib0030","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1213\/00000539-199107000-00016","article-title":"Bronchospasm after intramuscular 15-methyl prostaglandin F2 alpha and endotracheal intubation in a nonasthmatic patient","volume":"73","author":"Cooley","year":"1991","journal-title":"Anesth Analg"},{"key":"10.1016\/j.ajogmf.2022.100731_bib0031","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1111\/j.1471-0528.2006.01227.x","article-title":"Life-threatening bronchospasm after intramuscular carboprost for postpartum haemorrhage","volume":"114","author":"Harber","year":"2007","journal-title":"BJOG"},{"key":"10.1016\/j.ajogmf.2022.100731_bib0032","unstructured":"Hemabate. Carboprost tromethamine. 2013. Available at: https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2013\/017989s019lbl.pdf. Accessed April 21, 2022."},{"key":"10.1016\/j.ajogmf.2022.100731_bib0033","unstructured":"Cyklokapron. Tranexamic acid injection. 2013. Available at: https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2017\/019281s041lbl.pdf. Accessed April 21, 2022."},{"key":"10.1016\/j.ajogmf.2022.100731_bib0034","doi-asserted-by":"crossref","first-page":"2105","DOI":"10.1016\/S0140-6736(17)30638-4","article-title":"Effect of early tranexamic acid administration on mortality, hysterectomy, and other morbidities in women with post-partum haemorrhage (WOMAN): an international, randomised, double-blind, placebo-controlled trial","volume":"389","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.ajogmf.2022.100731_bib0035","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1056\/NEJMoa1800942","article-title":"Tranexamic acid for the prevention of blood loss after vaginal delivery","volume":"379","author":"Sentilhes","year":"2018","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ajogmf.2022.100731_bib0036","doi-asserted-by":"crossref","first-page":"3368","DOI":"10.1080\/14767058.2019.1571576","article-title":"Prophylactic use of tranexamic acid after vaginal delivery reduces the risk of primary postpartum hemorrhage","volume":"33","author":"Saccone","year":"2020","journal-title":"J Matern Fetal Neonatal Med"},{"key":"10.1016\/j.ajogmf.2022.100731_bib0037","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1056\/NEJMoa2028788","article-title":"Tranexamic acid for the prevention of blood loss after cesarean delivery","volume":"384","author":"Sentilhes","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ajogmf.2022.100731_bib0038","doi-asserted-by":"crossref","first-page":"S779","DOI":"10.1016\/j.ajog.2021.12.020","article-title":"LB 3: Tranexamic acid for the prevention of obstetrical hemorrhage after cesarean delivery: a randomized controlled trial","volume":"226","author":"Pacheco","year":"2022","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajogmf.2022.100731_bib0039","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1213\/ANE.0000000000000398","article-title":"Patterns of second-line uterotonic use in a large sample of hospitalizations for childbirth in the United States: 2007-2011","volume":"119","author":"Bateman","year":"2014","journal-title":"Anesth Analg"},{"key":"10.1016\/j.ajogmf.2022.100731_bib0040","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/s13321-015-0066-6","article-title":"Quantitative modeling of dose-response and drug combination based on pathway network","volume":"7","author":"Gu","year":"2015","journal-title":"J Cheminform"},{"key":"10.1016\/j.ajogmf.2022.100731_bib0041","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.3389\/fphar.2019.01222","article-title":"Isobologram analysis: a comprehensive review of methodology and current research","volume":"10","author":"Huang","year":"2019","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.ajogmf.2022.100731_bib0042","doi-asserted-by":"crossref","first-page":"421","DOI":"10.4097\/kjae.2010.58.5.421","article-title":"Drug interaction: focusing on response surface models","volume":"58","author":"Lee","year":"2010","journal-title":"Korean J Anesthesiol"},{"key":"10.1016\/j.ajogmf.2022.100731_bib0043","unstructured":"Alliance Pharmaceuticals. Syntometrine 500 micrograms\/5 IU solution for injection (ampoules). 2016. Available at: https:\/\/www.medicines.org.uk\/emc\/product\/865\/smpc. Accessed April 28, 2022."},{"key":"10.1016\/j.ajogmf.2022.100731_bib0044","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1007\/s13224-014-0607-3","article-title":"The effect of combined oxytocin-misoprostol versus oxytocin and misoprostol alone in reducing blood loss at cesarean delivery: a prospective randomized double-blind study","volume":"65","author":"Pakniat","year":"2015","journal-title":"J Obstet Gynaecol India"}],"container-title":["American Journal of Obstetrics & Gynecology MFM"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S258993332200163X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S258993332200163X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T23:50:17Z","timestamp":1762905017000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S258993332200163X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2]]},"references-count":43,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2023,2]]}},"alternative-id":["S258993332200163X"],"URL":"https:\/\/doi.org\/10.1016\/j.ajogmf.2022.100731","relation":{},"ISSN":["2589-9333"],"issn-type":[{"value":"2589-9333","type":"print"}],"subject":[],"published":{"date-parts":[[2023,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Preventing postpartum hemorrhage with combined therapy rather than oxytocin alone","name":"articletitle","label":"Article Title"},{"value":"American Journal of Obstetrics & Gynecology MFM","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajogmf.2022.100731","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"100731"}}